Home > Tools & Resources > FLUAD® QUADRIVALENT Real-World Evidence (RWE) Studies

FLUAD® QUADRIVALENT Real-World Evidence (RWE) Studies

Consider both clinical trial and RWE data when choosing an influenza vaccine. Explore RWE studies across multiple influenza seasons to learn more about the clinical effectiveness of FLUAD QUADRIVALENT (Influenza Vaccine, Adjuvanted).

Download
Flashcard that highlights FLUAD QUADRIVALENT and its clinical effectiveness for adults 65+ years.

Resource Notes:

Attributes Checklist
  • Presents 20+ years of RWE studies
  • Details findings by end points, study results, seasons, study design, and key limitations
  • Includes FLUAD® (Influenza Vaccine, Adjuvanted) vs standard-dose and high-dose influenza vaccines

Additional Resources

Flyer that highlights FLUCELVAX QUADRIVALENT and its clinical effectiveness for patients 6+ months.

FLUCELVAX QUADRIVALENT | CLINICAL

FLUCELVAX® QUADRIVALENT Real-World Evidence (RWE) Studies

See the RWE of FLUCELVAX QUADRIVALENT (Influenza Vaccine) over multiple seasons for a more complete picture of how it may impact influenza-related clinical outcomes.

Informative flyer that details why FLUAD QUADRIVALENT (Influenza Vaccine, Adjuvanted), an MF59® adjuvanted flu vaccine, is an appropriate option for patients 65+.

FLUAD QUADRIVALENT | CLINICAL

FLUAD® QUADRIVALENT Informational Flyer

Informative flyer that details why FLUAD QUADRIVALENT (Influenza Vaccine, Adjuvanted), an MF59® adjuvanted flu vaccine, is an appropriate option for patients 65+.

A brochure designed to educate patients about vaccination with FLUAD QUADRIVALENT (Influenza Vaccine, Adjuvanted).

FLUAD QUADRIVALENT | CLINICAL

FLUAD® QUADRIVALENT Patient Brochure

Educate patients about vaccination with FLUAD QUADRIVALENT (Influenza Vaccine, Adjuvanted).